WEHI researchers have uncovered a new way to help identify babies and fetuses at high-risk of developing brain bleeds, paving the way for better early intervention.
May 2, 2022
0
9
When you first break a bone, the body sends out an inflammatory response, and cells begin to form a hematoma around the injured area. Within a week or two, that blood clot is replaced with a soft material called callus that ...
May 2, 2022
0
64
Issues around vaccine acceptance must be addressed alongside equity of access and logistics if the goal of vaccinating 70% of the world's population against COVID-19 is to be met, says a report by global health policy experts.
Apr 27, 2022
0
4
Research from the Yale School of Medicine indicates that a protein kinase that is a master regulator of cell metabolism is critical to preventing atrial fibrillation. The research appeared April 22 in the journal JCI Insight.
Apr 26, 2022
0
42
Adults (aged 18 or older) hospitalized with COVID-19 are at higher risk of complications and death than those with influenza, despite being younger and having fewer chronic illnesses, according to a retrospective cohort study ...
Apr 22, 2022
0
140
Scientists have shown in an animal model that the CXCL12 messenger could be suitable as a target structure for the treatment of blood-clotting disorders.
Apr 21, 2022
0
2
Portable MRI machines, an emerging technology that makes medical imaging accessible even in remote locations, detected ischemic strokes, or strokes caused by clotting, in 90% of patients scanned, according to a study led ...
Apr 20, 2022
0
86
Almost two thirds of acute stroke patients fail to survive more than a decade and have high risk of recurrence, prompting researchers to call for better patient care.
Apr 15, 2022
0
35
Researchers have published the results of a clinical trial that led the U.S. Food and Drug Administration to recently approve mitapivat for the treatment of adults with pyruvate kinase deficiency—a rare genetic condition ...
Apr 14, 2022
0
31
A new Blood Advances study suggests that people with cancer and non-O blood types, such as types A, B, and AB, face an increased risk of developing venous thromboembolism (VTE), or blood clots in the veins, three months ...
Apr 13, 2022
0
9
